{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Lincoln S"],"funding":["Association of Academic Physiatrists","National Institute on Disability, Independent Living, and Rehabilitation Research","U.S. Department of Defense","National Institutes of Health","NIAMS NIH HHS","Craig H. Neilsen Foundation"],"pagination":["910934"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9388741"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["13"],"pubmed_abstract":["Spinal cord injury is often followed by osteoporosis characterized by rapid and severe bone loss. This leads to an increased risk of osteoporotic fracture in people with spinal cord injury, resulting in increased healthcare costs, morbidity, and mortality. Though it is common, the mechanisms underlying this osteoporosis are not completely understood and treatment options are limited. No biomarkers have been identified for predicting fracture risk. In this study, we sought to investigate microRNA mediated mechanisms relating to osteoporosis following spinal cord injury. We studied subjects with acute SCI (n=12), chronic SCI (n=18), and controls with no SCI (n=23). Plasma samples from all subjects underwent transcriptomic analysis to quantify microRNA expression, after which miR-148a-3p was "],"journal":["Frontiers in endocrinology"],"pubmed_title":["MicroRNA-148a-3p is a candidate mediator of increased bone marrow adiposity and bone loss following spinal cord injury."],"pmcid":["PMC9388741"],"funding_grant_id":["R01 AR064793"],"pubmed_authors":["Troy K","Mattson N","Nguyen N","Battaglino RA","Lincoln S","Morse LR"],"additional_accession":[]},"is_claimable":false,"name":"MicroRNA-148a-3p is a candidate mediator of increased bone marrow adiposity and bone loss following spinal cord injury.","description":"Spinal cord injury is often followed by osteoporosis characterized by rapid and severe bone loss. This leads to an increased risk of osteoporotic fracture in people with spinal cord injury, resulting in increased healthcare costs, morbidity, and mortality. Though it is common, the mechanisms underlying this osteoporosis are not completely understood and treatment options are limited. No biomarkers have been identified for predicting fracture risk. In this study, we sought to investigate microRNA mediated mechanisms relating to osteoporosis following spinal cord injury. We studied subjects with acute SCI (n=12), chronic SCI (n=18), and controls with no SCI (n=23). Plasma samples from all subjects underwent transcriptomic analysis to quantify microRNA expression, after which miR-148a-3p was ","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-22T21:52:29.717Z","creation":"2025-02-19T01:28:20.736Z"},"accession":"S-EPMC9388741","cross_references":{"pubmed":["35992108"],"doi":["10.3389/fendo.2022.910934"]}}